Endoscopic Ultrasound Guided Tissue Sampling (The ProCore Study)
ISRCTN | ISRCTN99035319 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN99035319 |
Secondary identifying numbers | 14399 |
- Submission date
- 28/06/2013
- Registration date
- 28/06/2013
- Last edited
- 15/07/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Ms Denise Norris
Scientific
Scientific
Queens Medical Centre
Derby Road
Nottingham
NG7 2UH
United Kingdom
Study information
Study design | Randomised interventional diagnostic accuracy trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised parallel trial |
Study setting(s) | Hospital |
Study type | Diagnostic |
Scientific title | A multi-centre randomised trial comparing EUS guided fine needle aspiration cytology (FNAC) with fine needle aspiration biopsy (FNAB) in sampling solid pancreatic mass lesions |
Study acronym | The ProCore Study |
Study objectives | The aim of this study is to investigate the diagnostic accuracy of the standard FNAC needle compared with the new FNAB needle in the sampling of solid pancreatic lesions. |
Ethics approval(s) | 12/EM/0189 |
Health condition(s) or problem(s) studied | Topic: Oral and Gastrointestinal; Subtopic: Oral and Gastrointestinal (all Subtopics); Disease: Gastrointestinal |
Intervention | Complications, Immediate complications, if any, will be recorded after the procedure. Patients will be contacted 30 days after the procedure to record any late complication.; Tissue Sampling, On the day of the procedure the patient will be consented for the procedure and for the study and will be randomised to either to obtain biopsy using 22G/25G FNAC needle citology or to obtain biopsy using 22G/25G FNAB needle. Linear and/or Radial EUS scopes will be used to identify and to take biopsy from the suspected lesion. Samples will be obtained according to the standard protocol. According to the published data we have assumed a diagnostic accuracy of 70% using EUS-FNAC, and this to be increased to 85% using EUS-FNAB needle. To detect the difference with a p value of 0.05 (two tailed) in the two groups with 80% power we will need to recruit 134 in each group. |
Intervention type | Other |
Primary outcome measure | Diagnostic accuracy of the standard FNAC needle compared with the new FNAB needle |
Secondary outcome measures | 1. Adequacy of the sample obtained with the FNAC needle compared with the new FNAB needle 2. Cost analysis using the FNAC needle compared with the FNAB needle 3. Number of passes needed in obtaining adequate sample using FNAC needle compared with the FNAB needle 4. Time taken in obtaining adequate sample using the FNAC needle compared with the FNAB needle |
Overall study start date | 01/09/2012 |
Completion date | 01/03/2014 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | Planned Sample Size: 268; UK Sample Size: 268 |
Key inclusion criteria | 1. Adult patients 18 years and above with a solid pancreatic mass of any size, needing to undergo EUS examination to collect sample for diagnosis. Definition of a solid pancreatic mass will be based on an ultrasound, CT scan or on the findings of a prior EUS. 2. Patients should have the ability and be willing to give informed consent. |
Key exclusion criteria | 1. Cystic lesions of the pancreas. 2. Patients known to be intolerant to endoscopy. 3. Patients not clinically fit for endoscopy as judged by their cariong team. 4. Patients on anticoagulation therapy. 5. Patients already participating in another trial. |
Date of first enrolment | 01/09/2012 |
Date of final enrolment | 01/03/2014 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Queens Medical Centre
Nottingham
NG7 2UH
United Kingdom
NG7 2UH
United Kingdom
Sponsor information
University of Nottingham (UK)
University/education
University/education
Wolfson Digestive Diseases Centre
South Block
C-Floor, Queens Medical Centre
Derby Road
Nottingham
NG7 2UH
England
United Kingdom
Website | http://www.nottingham.ac.uk/ |
---|---|
https://ror.org/01ee9ar58 |
Funders
Funder type
Industry
Cook Medical
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
15/07/2016: No publications found, verifying study status with principal investigator.